Skip to main content
NewslettersWatchlist

Zai Lab Ltd ADR(ZLAB-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low19.31
Day High20.01
Open:19.84
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months
Motley Fool
Why Shares of Zai Lab Limited Were Jumping on Tuesday
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB
PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Zai Lab Limited Investors to Inquire About Securities Class Action Investigation - ZLAB
PR Newswire
ZLAB ALERT: The Law Offices of Vincent Wong Investigate Zai Lab Limited for Potential Violations of Securities Laws
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB
PR Newswire
ZLAB INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited
PR Newswire
ZLAB NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited
PR Newswire
ROSEN, A LEADING LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLAB
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB
PR Newswire
ZLAB INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLAB
PR Newswire
ZLAB FRAUD ALERT: Jakubowitz Law is Investigating Zai Lab Limited in Connection with Potential Violations of Federal Securities Laws
PR Newswire
ZLAB ALERT: The Law Offices of Vincent Wong Investigate Zai Lab Limited for Potential Violations of Securities Laws
PR Newswire
ZLAB NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited
PR Newswire
ZLAB INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited
Motley Fool
Why Shares of Zai Lab Are Dropping Wednesday
Motley Fool
Why Shares of Alibaba, PDD, and Zai Lab Are Rising Today
Motley Fool
1 Hot Growth Stock to Buy Hand Over Fist Before It Blasts Off
Motley Fool
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Motley Fool
2 Stocks That Could Rebound and Rise 30% or More in 2023
Motley Fool
Why Shares of MacroGenics Jumped Thursday
Motley Fool
2 Growth Stocks With Incredible Potential in the Next 5 Years
MarketBeat
3 More Mid-Cap Biotechs The Street Sees Doubling
PR Newswire
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
Motley Fool
Why Shares of Zai Lab Soared This Week
Motley Fool
This Good News on Cancer Sent 2 Nasdaq Stocks Soaring
PR Newswire
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
Business Wire
Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv)
Globe Newswire
Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
PR Newswire
Qiming's Portfolio Company InventisBio Lists on STAR Market
Globe Newswire
Zai Lab to Announce Second Quarter 2022 Financial Results on August 9, 2022

Profile

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.